NCT06812455View on ClinicalTrials.gov

Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2029

Conditions
Radial Artery Occlusion
Interventions
DRUG

Rivaroxaban

Patients with RAO that will receive p.o. tabs Rivaroxaban 20 mg q.d.

Trial Locations (1)

54636

RECRUITING

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

AHEPA University Hospital

OTHER